Veru (STU:FMW0) Net Margin %: 0.00% (As of Mar. 2026)


STU:FMW0 Veru Inc STU:FMW0
28 GF Score
Price €3.11
! 2 Warning Signs
View Full Analysis

What is Veru Net Margin %?

Veru STU:FMW0 28 Net Margin % is 0.00% as of Mar. 2026. GuruFocus rates STU:FMW0 with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 941 Biotechnology companies, Veru ranks worse than 106269.82% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Veru's Net Income for the three months ended in Mar. 2026 was €-2.37 Mil. Veru's Revenue for the three months ended in Mar. 2026 was €0.00 Mil. Therefore, Veru's net margin for the quarter that ended in Mar. 2026 was 0.00%.

The historical rank and industry rank for Veru's Net Margin % or its related term are showing as below:


STU:FMW0's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -88.3
* Ranked among companies with meaningful Net Margin % only.

Veru  (STU:FMW0) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Veru Net Margin % Related Terms


Veru Net Margin % Historical Data

* Premium members only.

The historical data trend for Veru's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veru Net Margin % Chart

Veru Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.07 -213.55 -571.60 0.00 0.00

Veru Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STU:FMW0 vs AURX, PDSB, LTRN: Net Margin % Comparison

For the Biotechnology subindustry, Veru's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Veru Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Veru's Net Margin % distribution charts can be found below:

* The bar in red indicates where Veru's Net Margin % falls into.


STU:FMW0
28GF Score
Veru Inc STU:FMW0
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veru Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Veru's Net Margin for the fiscal year that ended in Sep. 2025 is calculated as

Net Margin=Net Income (A: Sep. 2025 )/Revenue (A: Sep. 2025 )
=-19.363/0
= %

Veru's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-2.371/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Veru (STU:FMW0) has a Net Margin % of 0.00% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Veru and its competitors. According to the industry distribution chart, Veru ranks #999999 out of 941 companies in the Biotechnology industry.
Is Veru's Net Margin % too high?
Veru's current Net Margin % is 0.00%. Based on the distribution chart, Veru ranks #999999 out of 941 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Veru has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Veru's Net Margin % compare to AURX and PDSB?
According to the Biotechnology industry distribution chart, Veru ranks #999999 out of 941 companies for Net Margin %. This places Veru in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Veru and its competitors. Veru's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veru stock overvalued right now?
Veru (STU:FMW0) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Veru's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Veru (STU:FMW0), the current Net Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Veru Business Description

Other Exchanges VERU:USA
Address 2916 North Miami Avenue, Suite 1000, Miami, FL, USA, 33127
Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.
28GF Score

Get the complete analysis for STU:FMW0

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.11
Price